Abstract
The major role of memory T cells is to ensure protection upon re-exposure to pathogens through rapid clonal proliferation and functional activation. This immunity usually persists for periods which can extend for over 60 years. These memory T cells are generated during acute viral infections. In the context of influenza viral infection, the presence of neutralizing antibodies against influenza virus proteins provides the first line of defense that prevents viral colonization and replication. Long-lasting humoral protective immunity is also needed for protection. However, antibodies against one subtype are usually inefficient in providing protection against other subtypes in humans. Major cytotoxic T-cell responses are usually targeted against conserved internal viral proteins. Moreover, the generated CTL responses are cross-reactive between influenza subtypes. In this review, we will discuss the generation and persistence of memory T cells and the role they play during influenza viral infection. An overview of new vaccine approaches aiming at the development of protective T-cell immune memory against influenza infection will also be provided.
Keywords: Influenza viral infection, Effector memory T cells, Central memory T cells, Acute viral infection, chronic viral infections
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Role of Memory T Cells in Influenza Viral Infection
Volume: 7 Issue: 2
Author(s): Rabih Halwani, Mehrnoosh Doroudchi, Mohamed El-Far, Andre Tanel, Yu Shi, Bader Yassine-Diab and Rafick-Pierre Sekaly
Affiliation:
Keywords: Influenza viral infection, Effector memory T cells, Central memory T cells, Acute viral infection, chronic viral infections
Abstract: The major role of memory T cells is to ensure protection upon re-exposure to pathogens through rapid clonal proliferation and functional activation. This immunity usually persists for periods which can extend for over 60 years. These memory T cells are generated during acute viral infections. In the context of influenza viral infection, the presence of neutralizing antibodies against influenza virus proteins provides the first line of defense that prevents viral colonization and replication. Long-lasting humoral protective immunity is also needed for protection. However, antibodies against one subtype are usually inefficient in providing protection against other subtypes in humans. Major cytotoxic T-cell responses are usually targeted against conserved internal viral proteins. Moreover, the generated CTL responses are cross-reactive between influenza subtypes. In this review, we will discuss the generation and persistence of memory T cells and the role they play during influenza viral infection. An overview of new vaccine approaches aiming at the development of protective T-cell immune memory against influenza infection will also be provided.
Export Options
About this article
Cite this article as:
Halwani Rabih, Doroudchi Mehrnoosh, El-Far Mohamed, Tanel Andre, Shi Yu, Yassine-Diab Bader and Sekaly Rafick-Pierre, Role of Memory T Cells in Influenza Viral Infection, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2008; 7 (2) . https://dx.doi.org/10.2174/187152308784533186
DOI https://dx.doi.org/10.2174/187152308784533186 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structure Activity Relationships for Nicotinamide in the Treatment of Stroke
Letters in Drug Design & Discovery Application of dsRNA in Cancer Immunotherapy: Current Status and Future Trends
Anti-Cancer Agents in Medicinal Chemistry Pharmacogenomics of Open-Angle Glaucoma
Current Pharmacogenomics and Personalized Medicine Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology
Current Pharmaceutical Design Evaluation of the Pharmacological Descriptors Related to the Induction of Antidepressant Activity and its Prediction by QSAR/QRAR Methods
Mini-Reviews in Medicinal Chemistry Metabolites of Dietary Protein and Peptides by Intestinal Microbes and their Impacts on Gut
Current Protein & Peptide Science Nanodiagnostic Attainments and Clinical Perspectives on C-Reactive Protein: Cardiovascular Disease Risks Assessment
Current Medicinal Chemistry Synthesis of Novel Imine Stilbene Analogs Exhibiting Potent Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Vatairea Macrocarpa Lectin Induces Paw Edema With Leukocyte Infiltration.
Protein & Peptide Letters Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review
Current Neuropharmacology Prospects for the Therapeutic Application of Lentivirus-Based Gene Therapy to HIV-1 Infection
Current Gene Therapy The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy
Current Medicinal Chemistry Exhaled Breath Condensate in Asthma: From Bench to Bedside
Current Medicinal Chemistry Synthetic Inhibitors of Group IVA and Group VIA Phospholipase A2
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry High Fat Diet and Gut Barrier Function
Current Nutrition & Food Science Corticoisteroid-Induced Apoptosis in Hematological Malignancies
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Risk Scores for Patients with Chest Pain: Evaluation in the Emergency Department
Current Cardiology Reviews Nutrigenomics and Personalized Diet: What are the Anticipated Impacts for Research on Chronic Diseases and Public Health?
Current Pharmacogenomics and Personalized Medicine